Gandaglia Giorgio, Zaffuto Emanuele, Fossati Nicola, Bandini Marco, Suardi Nazareno, Mazzone Elio, Dell'Oglio Paolo, Stabile Armando, Freschi Massimo, Montorsi Francesco, Briganti Alberto
Unit of Urology/Division of Oncology, URI, IRCCS San Raffaele Hospital, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.
BJU Int. 2018 Mar;121(3):421-427. doi: 10.1111/bju.14066. Epub 2017 Nov 27.
To assess if the preoperative lymph node invasion (LNI) risk could be used to tailor the extent of pelvic lymph node dissection (PLND) according to individual profile in patients with prostate cancer (PCa) undergoing radical prostatectomy (RP), and to identify those who would benefit from the removal of the common iliac and pre-sacral nodes.
A total of 471 patients with high-risk PCa treated with RP and a super-extended PLND that included the removal of the pre-sacral and common iliac nodes between 2006 and 2016 were identified. The risk of LNI was calculated according to the Briganti nomogram. Multivariable logistic regression analyses assessed the association between LNI risk and involvement of the common iliac and pre-sacral regions. The risk of positive common iliac and pre-sacral nodes was plotted over the LNI risk using the LOWESS-smoothed fit curve.
The median preoperative LNI risk was 25.5%. The median number of nodes removed was 23, and 171 (36.3%) patients had LNI. Overall, 61 (13.0%) and 28 patients (5.9%), respectively, had positive common iliac and pre-sacral nodes alone or in combination with other sites. The LNI risk was associated with the involvement of the common iliac and pre-sacral regions (all P < 0.001). The proportion of patients with positive common iliac and pre-sacral nodes progressively increased according to the LNI risk. The adoption of a 30% threshold would result in avoiding the removal of the common iliac and pre-sacral nodes in >60% cases, with a risk of missing LNI in these regions of <5%.
Fewer than 5% of patients with an LNI risk of <30% harbour positive common iliac and pre-sacral nodes. A super-extended PLND that includes the dissection of these regions should be considered exclusively in patients with an LNI risk ≥30%.
评估术前淋巴结侵犯(LNI)风险是否可用于根据接受根治性前列腺切除术(RP)的前列腺癌(PCa)患者的个体情况调整盆腔淋巴结清扫术(PLND)的范围,并确定哪些患者将从切除髂总淋巴结和骶前淋巴结中获益。
共纳入2006年至2016年间接受RP及包括切除骶前和髂总淋巴结的超扩大PLND治疗的471例高危PCa患者。根据Briganti列线图计算LNI风险。多变量逻辑回归分析评估LNI风险与髂总及骶前区域受累之间的关联。使用LOWESS平滑拟合曲线将髂总及骶前淋巴结阳性风险绘制在LNI风险之上。
术前LNI风险中位数为25.5%。切除淋巴结的中位数为23个,171例(36.3%)患者存在LNI。总体而言,分别有61例(13.0%)和28例(5.9%)患者单独或与其他部位联合出现髂总或骶前淋巴结阳性。LNI风险与髂总及骶前区域受累相关(所有P<0.001)。髂总及骶前淋巴结阳性患者的比例随LNI风险逐渐增加。采用30%阈值可在>60%的病例中避免切除髂总及骶前淋巴结,这些区域漏诊LNI的风险<5%。
LNI风险<30%的患者中,髂总及骶前淋巴结阳性的患者少于5%。仅应考虑对LNI风险≥30%的患者进行包括这些区域清扫的超扩大PLND。